Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive SOD1 ALS.

about

Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive SOD1 ALS.

Item

http://www.wikidata.org/entity/Q47648367

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Randomized, double-blind, plac ...... rapidly progressive SOD1 ALS.

@en

Randomized, double-blind, plac ...... rapidly progressive SOD1 ALS.

@nl

type

Item

label

Randomized, double-blind, plac ...... rapidly progressive SOD1 ALS.

@en

Randomized, double-blind, plac ...... rapidly progressive SOD1 ALS.

@nl

prefLabel

Randomized, double-blind, plac ...... rapidly progressive SOD1 ALS.

@en

Randomized, double-blind, plac ...... rapidly progressive SOD1 ALS.

@nl

P1476

Randomized, double-blind, plac ...... rapidly progressive SOD1 ALS.

@en

P2093

David Schoenfeld

http://www.w3.org/2001/XMLSchema#string

Joanne Wuu

http://www.w3.org/2001/XMLSchema#string

Nazem Atassi

http://www.w3.org/2001/XMLSchema#string

William David

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical significance in the change of decline in ALSFRS-R

Upregulation of heat shock proteins rescues motoneurones from axotomy-induced cell death in neonatal rats

Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice

Pyrimethamine decreases levels of SOD1 in leukocytes and cerebrospinal fluid of ALS patients: a phase I pilot study

Late stage treatment with arimoclomol delays disease progression and prevents protein aggregation in the SOD1 mouse model of ALS

Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis

The PRO-ACT database: design, initial analyses, and predictive features

Shared parameter models for the joint analysis of longitudinal data and event times.

Systematically perturbed folding patterns of amyotrophic lateral sclerosis (ALS)-associated SOD1 mutants

Arimoclomol at dosages up to 300 mg/day is well tolerated and safe in amyotrophic lateral sclerosis.

P304

e565-e574

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0000000000004960

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael Benatar

Peter M Andersen

Merit E Cudkowicz

P577

2018-01-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29367439

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis

placebo

P932

5818014

http://www.w3.org/2001/XMLSchema#string